Director, Division of Pediatric Nephrology UAB School of Medicine
Pediatric Nephrology
Dr. Daniel Feig, MD
|
|
Give Review
Daniel Feig, MD works in the field of Pediatric Nephrology. He attended University of Washington School of Medicine. He over the years received 3 awards: "Regional Top Doctor", "Super Doctor" and "Fellow (FAAP)". Daniel Feig is a published doctor as well. He has 58 publications published. The latest was: Mechanisms of mutation by oxidative DNA damage: reduced fidelity of mammalian DNA polymerase beta. He is registered with Medicare.
Publications
- Obstructive sleep apnea and periodic limb movement disorder in a population of children with Hypertension and/or nocturnal nondipping blood pressures.
- Serum Uric Acid and Risk of CKD in Type 2 Diabetes.
- Serum uric acid and the risk of hypertension and chronic Kidney disease.
- Serum urate: a biomarker or treatment target in pediatric Hypertension?
- The utility of cortical-sparing adRenalectomy in pheochromocytomas associated with genetic syndromes.
- What Are the Key Arguments Against Uric Acid as a True Risk Factor for Hypertension?
- Uric Acid and the Origins of Hypertension.
- Uric acid reduction rectifies preHypertension in obese adolescents.
- Association between left ventricular mass index and cardiac function in pediatric dialysis patients.
- Uric Acid and Hypertension.
- Serum uric acid is associated with high blood pressure in pediatric hemodialysis patients.
- Safety and efficacy of intravenous labetalol for Hypertensive crisis in infants and small children.
- Uric acid and Hypertension: cause or effect?
- Sour notes on sweet drinks.
- Prenatal programming: maybe not so hopeless after all?
- Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes?
- Cost-effectiveness of ambulatory blood pressure monitoring in the initial evaluation of Hypertension in children.
- Uric acid and cardiovascular risk.
- Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential Hypertension: a randomized trial.
- Recent advances in the diagnosis and treatment of pheochromocytoma in children.
- Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, Kidney disease, and cardiovascular disease.
- Inaccuracy in pediatric outpatient blood pressure measurement.
- The role of uric acid in pediatric Hypertension.
- Nephron number, uric acid, and renal microvascular Disease in the pathogenesis of essential hypertension.
- Serum uric acid: a risk factor and a target for treatment?
- A causal role for uric acid in fructose-induced metabolic Syndrome.
- A unifying pathway for essential Hypertension.
- Uric acid and Hypertension in adolescents.
- Hypothesis: Uric acid, nephron number, and the pathogenesis of essential Hypertension.
- Management of a severe carbamazepine overdose using albumin-enhanced continuous venovenous hemodialysis.
- Hyperuricemia in childhood primary Hypertension.
- Sugar-sweetened beverages and Hypertension.
- Pathogenesis of essential Hypertension: historical paradigms and modern insights.
- Childhood hypertension is not a silent Disease.
- A sensitive and specific liquid chromatography-tandem mass spectrometry method for the determination of intracellular and extracellular uric acid.
- Uric acid: a novel mediator and marker of risk in chronic Kidney disease?
- Uncontrolled Hypertension in children on hemodialysis.
- Minimal change Disease with IgM+ immunofluorescence: a subtype of nephrotic syndrome.
- Frequent hemodialysis with NxStage system in pediatric patients receiving maintenance hemodialysis.
- Hormonal and cytokine effects of uric acid.
- Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular Disease? An old controversy renewed.
- Resurrection of uric acid as a causal risk factor in essential Hypertension.
- Subtle Renal injury is likely a common mechanism for salt-sensitive essential hypertension.
- Diuretic-induced hyperuricemia does not decrease cardiovascular risk.
- The C proteins of heterogeneous nuclear ribonucleoprotein complexes interact with RNA sequences downstream of polyadenylation cleavage sites.
- Reverse chemical mutagenesis: identification of the mutagenic lesions resulting from reactive oxygen species-mediated damage to DNA.
- Mutagenesis by metal-induced oxygen radicals.
- Reactive oxygen species in tumorigenesis.
- Oxygen radical induced mutagenesis is DNA polymerase specific.
- Mechanisms of mutation by oxidative DNA damage: reduced fidelity of mammalian DNA polymerase beta.
- 3-5 year longitudinal follow-up of pediatric patients after Acute renal failure.
- Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal Disease?
- Unearthing uric acid: an ancient factor with recently found significance in renal and cardiovascular Disease.
- Uric acid: a clinically useful marker to distinguish preeclampsia from gestational Hypertension.
- Coincident activation of Th2 T cells with onset of the Disease and differential expression of GRO-gamma in peripheral blood leukocytes in minimal change Disease.
- Calcium oxalate deposition in Renal allografts: morphologic spectrum and clinical implications.
- Prevalence of Acute kidney injury during pediatric admissions for Acute chest syndrome.
Schools
University Of Washington School Of Medicine
Chldns Hospital And Regl Med Center
Boston Children39s Hospital
Procedures Preformed
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Chronic Glomerulonephritis
- Chronic Kidney Diseases
- View All
Doctors Specialties
- Pediatric Nephrology
Accepted Insurances
Awards
- Regional Top Doctor
- Super Doctor
- Fellow (FAAP)
Education
-
Boston Children's Hospital -
University of Washington -
University of Washington School of Medicine
Hospital
-
Children's of Alabama -
University of Alabama Hospital
Drug Facts
| NPI NUMBER | 1942380290 | |
| NPPES Provider LastName | FEIG | |
| NPPES Provider FirstName | DANIEL | |
| NPPES Provider ZIPCode | 352331711 | |
| NPPES Provider State | AL | |
| Specialty Description | Pediatric Medicine | |
| Total Claim Count | 562.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1942380290 |
| Last Name Of The Provider | FEIG |
| First Name Of The Provider | DANIEL |
| View All |
Similar Doctors
|
|
Dr. Monica C. Tucci, DO
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David J. Askenazi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa Guay-Woodford, MD |
|
|
Dr. Sahar A. Fathallah-Shaykh, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mark R. Benfield, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ramzi A. Malek, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Megan V. Yanik, MD |
|
|
Dr. William F. Tenney, MD
This Doctor is OpenDoctor Recommended.
|